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ABSTRACT 
USING RNA SEQ TO DEFINE GENES AND PATHWAYS AFFECTING 
SALMONELLA VACCINE RESPONSE IN BEEF CATTLE 
SARA AWRAHMAN 
2017 
A Salmonella siderophore receptor and porin (SRP) proteins vaccine is an intervention 
strategy to control Salmonella burden in cattle. The vaccine works by stimulating 
immunity to produce antibodies against bacterial SRPs as siderophore molecules play a 
major role in transporting iron to bacteria. Blocking iron uptake system by antibodies 
causes death of bacterial cells. The vaccine can also be useful to protect humans against 
salmonellosis, which causes high rates of illness and death annually, by reducing 
shedding of Salmonella in the feces of cattle. Though other researchers have evaluated 
efficacy and immune response of this Salmonella SRP vaccine, genes and pathways 
affected by vaccination have not been investigated. Therefore, the aim of this study was 
to identify differentially expressed genes and pathways in bovine whole blood after 
vaccination with Salmonella SRPs by RNA sequencing. Five Angus cattle were 
vaccinated with the Salmonella SRP vaccine, and blood samples were collected at first 
day of vaccination, day 21 post-vaccination (time of booster vaccination) and finally day 
48 post-vaccination. To perform RNA seq, total RNA was extracted from blood samples 
using the PAXgeneTM Blood RNA kit. Library samples were prepared using the Illumina 
TruSeq Stranded Total RNA Library PrepKit and sequenced on an Illumina HiSeq 
sequencer. After processing raw sequencing reads, filtered data was aligned to the bovine 
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reference genome (Bta_4.6.1). Cuffdiff was used for pairwise differential expression 
analysis. The transcript abundance was normalized in Fragments Per Kilobase of 
transcript per Million mapped reads (FPKM). FDR adjusted p-values (q-value<0.05) 
were used to identify differentially expressed genes between 1) day 21 and day 0, and 2) 
day 48 and day 0 of vaccination. Of the 848 differentially expressed (DE) genes at day 21 
post-vaccination, one gene was increased in abundance and 26 genes were decreased in 
abundance with a fold-change >2. Of the 1155 DE genes at day 48 post-vaccination, 20 
genes were increased in abundance and 39 genes were decreased in abundance with a 
fold-change >2. DAVID bioinformatics was used to annotate a list of differentially 
expressed genes to their correlated GO terms and KEGG pathways using Bos Taurus as a 
background. Most decreased in abundance genes were annotated to biosynthetic 
processes of heme and protoporphyrinogen IX. FoxO signaling pathway, AMPK 
signaling pathway, and porphyrin and chlorophyll metabolism were found significantly 
decreased in abundance at day 21 post-vaccination. Real-time RT-PCR was used to 
validate RNA sequencing results for the day 48 to day 0 comparison. All three genes 
tested (HMB, ALAS2, and ATPIF1) were decreased in abundance at day 48 (P<0.05), 
confirming our RNA sequencing observations. Our analysis suggests that Salmonella 
SRP vaccination decreased in abundance pathways involving heme (iron) metabolism in 
bovine blood. 
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Chapter 1  
LITERATURE REVIEW 
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Introduction 
Vaccination is delivery of a foreign antigen into a body in order to stimulate its 
immunity by producing antibodies and memory cells to protect the body from actual 
disease. Livestock species are considered a potential source for foodborne Salmonella 
that can be transmitted from animals to humans through direct or indirect contact or 
consumption of contaminated meat. Salmonella are estimated to cause about 35% of 
hospitalizations and 28% of deaths by foodborne pathogens in the United States each 
year (Scallan et al., 2011). Therefore, attempts have been made to develop pre-harvest 
interventions that aid in the control of Salmonella in farm animals. For example, a 
siderophore based (SRP) vaccine is an intervention designed to induce animal immune 
response against bacterial siderophore proteins with the aim of reducing Salmonella 
populations. The efficacy of this vaccine has been evaluated. Some studies found the 
vaccine to be ineffective at reducing fecal shedding of Salmonella (Heider et al., 2008: 
Dodd et al., 2011; Cernicchiaro et al., 2016) but at least one study observed a reduction in 
fecal shedding (Loneragan et al., 2012). The reason for these conflicting results is 
unknown.  
Sequencing of the transcriptome by next generation RNA sequencing (“RNA 
seq”) enables scientists to identify differentially expressed transcripts and pathways 
correlated with different conditions without prior knowledge of gene sequences. In 
general, any NGS platform can be used to perform RNA seq though template preparation 
and data analysis steps may vary. Therefore, it is important for researchers to take into 
account the advantages and disadvantages of each system in terms of reagent cost, run 
time, read length, and other factors affecting cost, efficiency, and quantity and quality of 
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sequencing reads. RNA seq offers a wide range of applications such as discovery of 
novel transcripts and identification of genetic variants. For example, transcriptome 
profiling of bovine peripheral blood mononuclear cells by RNA seq has resulted in the 
discovery of putative biomarkers associated with vaccine response and disease resistance 
(Bhuju et al., 2012).  
Studying links between vaccination and differentially expressed genes in beef 
cattle will provide greater insights into the molecular and biological mechanisms of 
immune response. This information may contribute to the design of new vaccines. Also, 
mRNA transcriptome studies could allow for identification of biomarkers and pathways 
associated with immune response to vaccines in beef cattle. This literature review will 
include an overview of Salmonella subspecies in cattle and the interventions that can be 
taken to reduce its prevalence as well as a general background on RNA seq, next 
generation sequencing platforms, and applications of RNA seq in livestock species.  
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Salmonella spp 
Salmonella (nontyphoidal) species are common worldwide foodborne bacteria 
with over 2500 distinctive serotypes (WHO, 2013) based upon the structures of surface 
antigens (CDC, 2015). Nevertheless, some of these serotypes are specific to one host (S. 
Dublin in cattle and S. Choleraesuis in swine) while other serotypes can be present in a 
wide variety of hosts (S. Typhimurium and S. Enteritidis). All serotypes can be 
pathogenic to humans (WHO, 2013). Salmonella can survive outside the host and also 
colonize the gastrointestinal tract of domestic animals like cattle and poultry (Toldrá, 
2009) without obvious signs of disease (Sanchez et al., 2002). Transmission of 
Salmonella to humans usually occurs by the ingestion of raw foods and animal products 
contaminated with manure, or by contact with infected animals and their environment 
(Nester et al., 2004). Common manifestations of salmonellosis are abdominal pain, fever, 
diarrhea, and occasionally vomiting. These illnesses can be severe in infants, elderly 
people and immunocompromised individuals (WHO, 2013). 
 The disease and economic burden of Salmonella are more substantial than other 
foodborne bacteria due to its high morbidity and mortality rate (Scallan et al., 2011). An 
average of 93.8 million cases of non-typhoidal Salmonella infections are estimated to 
occur each year, including 155,000 deaths (Majowicz et al., 2010). Non-typhoidal 
Salmonella is a leading cause of foodborne illness in the United States, resulting in 
approximately one million illnesses annually (Scallan et al., 2011). Among 15 foodborne 
pathogens, Salmonella was the costliest disease examined with an estimated loss of 3.7 
billion US dollars each year (Hoffmann et al., 2015). Since cattle are primary reservoirs 
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for Salmonella enterica subspecies, people can become ill after consuming meat 
contaminated with Salmonella. To reduce and control the prevalence of Salmonella in 
cattle, pre-harvest interventions such as antibiotics and vaccines have been used. 
However, the effectiveness of each intervention can vary.   
Though antibiotics can be beneficial to treat and control salmonellosis in animals, 
their use has been restricted due to increasing resistance of serotypes to antibiotics 
(Barrow and Methner, 2013). These multidrug-resistant serotypes could be a major 
problem to public health because they can be transmitted from animals to humans 
through consumption of contaminated foods (DiMarzio et al., 2013). Furthermore, some 
antibiotics used in livestock are similar or identical to antibiotics used by humans 
(McEwen and Fedorka-Cray, 2002) although many antibiotics used in human medicine 
are too expensive to use in livestock and are not approved for use in animals. Salmonella 
typhimurium (Definitive Type 104), in particular, is resistant to a number of antibiotics, 
which includes ampicillin, chloramphenicol, streptomycin, sulphonamides, and 
tetracycline (Mather et al., 2013). However, this article also presents evidence that 
transmission of resistant DT 104 between animals and humans was limited, suggesting 
that livestock may not be important reservoirs of antibiotic-resistant bacteria in humans. 
More research into transmission of antibiotic-resistant bacteria to humans and alternatives 
to the use of antibiotics for control of Salmonella are necessary. 
  Vaccination is an alternate route of intervention to prevent and control 
Salmonella. Two groups of vaccines are available against Salmonella: inactivated and 
live-attenuated vaccines. Inactivated vaccines often stimulate weaker immune responses 
against Salmonella relative to live-attenuated vaccines because inactivated vaccines use 
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killed pathogens as the antigen. Thus, inactivated vaccines are incapable of mimicking 
real infections (nonimmunogenic) and elicit only humoral immunity (Elgert, 2009). 
Therefore, these vaccines can be ineffective at protecting animals against Salmonella 
serotypes. Subunit vaccines are a type of inactivated vaccine which is composed of 
antigenic peptide fragments of a pathogen. These peptides evoke an immune response. A 
subunit vaccine has been developed that is labeled to reduce the shedding of Salmonella 
in cattle; this vaccine may also provide cross-protection against more than one 
Salmonella strain (Heider et al., 2008). In contrast to inactivated vaccines, live attenuated 
vaccines are capable of triggering stronger immune responses against Salmonella and 
stimulate both cell-mediated and antibody-mediated (humoral) immunity (Barrow and 
Methner, 2013) because the live-vaccines include a weakened form of disease-causing 
agents (Elgert, 2009). For instance, in White Leghorn chickens, a live-attenuated vaccine 
was more effective than an inactivated vaccine in the induction of cell-mediated 
immunity because of the increased proliferation of lymphocytes against Salmonella 
enteritidis antigen among chickens (Babu et al., 2003).  
The Salmonella Newport Bacterial Extract vaccine manufactured by Epitopix 
targets Siderophore Receptors and Porin (SRP) proteins derived from the outer 
membrane of gram-negative Salmonella bacteria (Hermesch et al., 2008). These cell 
membrane proteins transport iron, which is a vital nutrient for bacterial survival and 
growth, into Salmonella bacteria. The vaccine is capable of activating the immune system 
to create antibodies that block the SRP proteins (iron transport system). Ultimately, the 
bacterial cell dies from lack of iron (Thomson et al., 2009). 
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Previous studies on Salmonella SRP vaccination have shown conflicting results 
on the efficacy of this vaccine as defined by reduction in shedding of Salmonella in the 
feces of beef and dairy cattle. Numerous experimental studies have indicated no 
significant difference in fecal shedding or prevalence of Salmonella between vaccine and 
control groups in dairy and feedlot cattle (Hermesch et al., 2008; Heider et al., 2008; 
Dodd et al., 2011; Cernicchiaro et al., 2016), whereas the result of an observational study 
on dairy cull cows indicated a difference in fecal prevalence of Salmonella between dairy 
herds that used Salmonella SRP vaccine and dairy herds that did not (Loneragan et al., 
2012).  
Dodd and colleagues (2011) carried out a study to ascertain how Salmonella SRP 
vaccination affects beef cattle performance, health, and fecal shedding of Salmonella 
bacteria. A total of 1,591 feedlot cattle with an average weight of 256 kg were enrolled in 
the experiment and were allocated to two treatment groups using 20 pens (10 pens per 
treatment group). One group (n=795) was inoculated with 2mL of Salmonella Newport 
SRP vaccine while a second group (n=796) was administrated a 2mL placebo. Cattle 
were revaccinated 21 days later with a booster shot. Feces were collected from each pen 
floor on day 0, 60, 120, and the day of harvest (day is relative to time of initial 
vaccination). The fecal samples were cultured for Salmonella detection. Weight gain, 
feed intake, and data on cattle health including morbidity and mortality were recorded. 
Data analysis of pen fecal prevalence were performed using linear mixed models. No 
statistically significant effect of the SRP vaccine on the performance and health of 
treatment (vaccine) vs. control groups, and also on the fecal shedding of Salmonella in 
vaccinated (10.2%) and control (10.9%) cattle were found. The authors concluded that 
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immunization of feedlot cattle with Salmonella SRP vaccine did not have an effect on the 
fecal shedding of Salmonella or on health and performance. 
Another study by Hermesch and colleagues (2008) examined the effects of 
Salmonella SRP vaccination on milk yield, somatic cell count (SCC), and fecal shedding 
of Salmonella bacteria in female dairy cattle. A total of 180 non-lactating Holstein cows 
and pregnant Holstein heifers were enrolled without apparent signs of salmonellosis. 
Cattle were randomly assigned to vaccinated or control groups. The initial dose of 
vaccine or control solution was administered to cattle approximately 45 to 60 days prior 
the expected parturition. The booster dose was inoculated 14 to 21 days prior to 
parturition. Blood and fecal samples for measurement of antibody response to Salmonella 
SRP vaccine and for detection of Salmonella, respectively, were collected on the day of 
initial inoculation, at 7 to 14 days of lactation, and at 28 to 35 days of lactation. Milk 
samples were collected to estimate somatic cell count (SCC). No statistically significant 
difference was found between treatment and control groups for milk production. The 
SCC in milk samples of vaccinated cattle was significantly lower than control cattle at 30 
to 60 days of lactation. However, no significant difference in SCC was detected between 
groups at other time points. Antibody titers of vaccinated cattle were higher than that of 
control cattle on days 7 to 14 of lactation and days 28 to 35 of lactation. No difference in 
prevalence of fecal shedding of Salmonella was detected between the two groups. 
Nonetheless, a significant decrease in the prevalence of Salmonella was found in both 
vaccinated and control groups at days 7-14 of lactation. The authors concluded 
immunization of healthy dairy cattle with the Salmonella Newport SRP protein vaccine 
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had no effect on reducing shedding of Salmonella bacteria even though the Salmonella 
SRP vaccine can decrease SCC and elicit an antibody response. 
Unlike the two previous findings, Loneragan et al. (2012) suggested that the use 
of Salmonella SRP vaccine at herd-level can help reduce the prevalence of Salmonella in 
dairy farms. Though the main objective of their study was to characterize the 
epidemiology of Salmonella harbored by dairy cattle culled from farms in the Texas High 
Plains, they also estimated the prevalence and concentration of Salmonella in feces. In 
total nine dairies were enrolled, of which three dairies vaccinated their entire herd with 
the Salmonella SRP vaccine while the remainder did not. The Salmonella SRP vaccine 
was correlated (P=0.05) with reduced prevalence of Salmonella. The prevalence was 8% 
among farms that used this vaccine while 36.8% among farms that didn’t use this 
vaccine. The authors concluded that the SRP vaccine might be useful for decreasing 
Salmonella prevalence. However, other factors besides vaccination might play a role in 
reducing Salmonella prevalence like biosecurity measures. Salmonella is still a serious 
problem for both animals and humans even with available pre-harvest interventions. 
Therefore, further research on different interventions can enable scientists to understand 
how to better control the spread of this bacteria. Genetic selection has potential to reduce 
salmonella prevalence by selecting cattle that elicit a stronger, more protective immune 
response after vaccination. It is important to mention that no study to our knowledge has 
investigated the genetic response of cattle to Salmonella SRP vaccination.  
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Overview of RNA Sequencing 
RNA-seq is an application of next-generation sequencing (NGS) methods to study 
ribonucleic acids (RNA molecules). This high-throughput sequencing technique is used 
for quantification of the transcriptome in a biological sample and for analysis of 
transcriptional changes between different experimental conditions in order to determine 
which genes or pathways may be affected by treatments. Besides differential gene 
expression (DGE), RNA-seq can be used for annotation and discovery of transcripts and 
also for identification of polyadenylation and alternative splicing. With this novel 
technique, quantitative and qualitative information can be obtained. Quantitative data is 
used for measuring differentially expressed genes, alternative transcription start sites 
(TSS), polyadenylation sites and alternative splicing under different conditions. 
Qualitative data allows for the identification of transcripts, transcription start sites, 5' and 
3' untranslated regions (UTR), and exon-intron boundaries (Kaundal, 2016).  
Transcriptomics aims to identify transcript function (small RNAs, non-coding 
RNAs, and messenger RNAs), to ascertain a gene’s transcriptional structure (splicing 
mechanisms, start sites and post-transcriptional modifications) and to quantify changes in 
the level of each expressed transcript in a given sample (Wang et al., 2009). For example, 
studies have used RNA-seq to ascertain patterns of alternative splicing (Wang et al., 
2008; Tremblay et al., 2016), levels of steady-state mRNA molecules (Bremer and 
Moyes, 2014), and discovery of novel non-coding RNAs and mRNAs (Guttman et al., 
2010; Djebali et al., 2012). Some applications related to livestock include the discovery 
of genetic variants (SNPs) (Cánovas et al., 2010), identification of small RNAs (Jin et al., 
2009), long noncoding RNAs (Billerey et al., 2014), and alternative splicing events 
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(Wang et al., 2016). Since RNA-seq has become a very common research tool, it is 
important to understand how this powerful technique works before the initiation of a 
RNA-seq study.  
One of the most common applications of RNA-Seq is to investigate differential 
gene expression (DGE) (Soneson et al., 2016). With DGE, up-regulated and down-
regulated genes can be identified after application of a specific experimental treatment 
(Wit et al., 2012). For DGE, polyadenylated mRNA is isolated from total RNAs via oligo 
deoxythymidine (dT) beads (Wang et al., 2009; Wilhelm and Landry, 2009; Corney and 
Basturea, 2013). Ribosomal RNA (rRNA) constitutes about 90% of cellular RNAs 
(Wilhelm and Landry, 2009; Zeng and Mortazavi, 2012). The rRNA is removed to allow 
increased sequencing coverage of the lower abundance mRNAs. The mRNA is converted 
to a library of double-stranded complementary DNA (cDNA) fragments with adapters 
ligated to both ends of each cDNA molecule (Wang et al., 2009; Chu and Corey, 2012; 
Wolf, 2013). After amplification of the cDNA library, cDNA fragments are deep 
sequenced to produce short sequences (Wang et al., 2009; Marguerat and Bähler, 2010; 
Corney and Basturea, 2013) from either one direction (single end) or both directions (pair 
end). These short sequences are called reads. Sequencing platforms generate digital data 
that include millions of short reads. The length of the reads is usually 30 to 400 base pairs 
and differs among sequencing platforms (Wang et al., 2009). These reads are directly 
mapped to a reference genome (Wang et al., 2009; Marguerat and Bähler, 2010; Wolf, 
2013; Finotello and Di Camillo, 2015) for transcript identification and DGE (Finotello 
and Di Camillo, 2015). The estimation of expression levels of a transcript is transformed 
to number of Reads Per Kilobase per Million mapped reads (RPKM) (Mortazavi et al., 
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2008) or to number of Fragments Per Kilobase of transcript per Million fragments 
mapped reads (FPKM) (Trapnell et al., 2010; Griffith et al., 2015). The RPKM and 
FPKM are used for DGE to prevent biased read distributions. A biased distribution may 
result from differences in sequencing depth among samples or differences in the length of 
RNA molecules in a sample. In principle, any NGS platform can be utilized to perform 
RNA seq (Finotello and Di Camillo, 2015; Chu and Corey, 2012). At present, the major 
NGS platforms are Illumina, Applied Biosystems (SOLiD), Roche 454, Ion Torrent, 
Pacific Biosciences, and Oxford Nanopore (Korpelainen et al., 2015; Levy and Myers, 
2016). Each platform utilizes distinct sequencing chemistry and detection techniques 
(Meldrum et al., 2011). 
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Next Generation Sequencing Platforms  
The NGS technologies above involve numerous steps that can be generally 
categorized as library construction, sequencing, imaging, and lastly data analysis. Library 
(or template) preparation for the sequencing reaction is classified as either amplification 
dependent or independent. In the amplification dependent platforms, after fragmentation 
and adapter ligation of cDNA, the DNA fragments are either attached to a flow cell, 
beads or ion surfaces. The bound DNA fragments are then subjected to clonal PCR 
amplification (Metzker, 2010), which is performed by emulsion PCR (Dressman et al., 
2003) or solid-phase bridge PCR (Fedurco et al., 2006). On the other hand, in the 
amplification independent platforms, the DNA is prepared by either the Single Molecule 
Real Time SMRTbell template technique or leader-hairpin template technique (Goodwin 
et al., 2016). With SMRTbell template, DNA is fragmented, and then two hairpin 
adapters are added to each end of the DNA. The hairpin adapters allow for continuous 
circular sequencing of the DNA. With leader-hairpin template technology used by 
Nanopore, after fragmentation, two distinct adapters (hairpin and leader) are added to 
each end of a DNA molecule. The hairpin adapter allows bidirectional sequencing while 
the leader interacts with a pore and motor protein to direct cDNA during sequencing. A 
single DNA molecule is then immobilized to either a Zero-Mode Waveguides (ZMW) 
well (Ambardar et al., 2016) or MinION flowcell (Lu et al., 2016) where the sequencing 
occurs.  
Additionally, NGS platforms use different strategies for sequencing and signal 
detection: cyclic reversible termination (Ju et al., 2006), single nucleotide addition 
(Metzker, 2010), sequencing by ligation (Garrido-Cardenas et al., 2017), single molecule 
 14
real time sequencing (Rhoads and Au, 2015) and single molecule nanopore sequencing 
(Levy and Myers, 2016). One major difference among these sequencing approaches aside 
from nanopore sequencing (no enzyme) is that either a DNA polymerase or ligase 
enzyme is required for nucleotide incorporation (Ambardar et al., 2016). Another 
difference is that signal detection is directly or indirectly recorded. Real time PCR 
(Pacific Biosciences) or electric current (Oxford Nanopore) is used for direct detection of 
signals. With indirect detection, signals are recorded at the end of each cycle by either a 
Charge Coupled Device (CCD) camera (Illumina, SOLiD, and Roche 454) or field-effect 
transistor sensors (Ion Torrent) (Levy and Myers, 2016). Sequencing platforms differ in 
data format and output, read length, error rate, and run time. As a result of these 
differences, a diversity of bioinformatics approaches is needed to handle data for 
appropriate quality control, alignment, assembly, and processing (Zhang et al., 2011; 
Egan et al., 2012).  
Three widespread deep-sequencing platforms that have been used by research 
laboratories, sequencing centers, and core facilities are Illumina, Roche 454 and SOLiD 
(Lister et al., 2009; Bai et al., 2012). The Illumina is the most commonly used technology 
and utilizes solid-phase amplification for cluster generation (Buermans and Den Dunnen, 
2014) and a cyclic reversible terminator (CRT) for sequencing (Kircher and Kelso, 2010).  
Clonally amplified clusters are produced by multiple amplification cycles of a single 
molecule DNA template (Voelkerding et al., 2009). The DNA fragments with ligated 
adapters on both ends are loaded onto a flow cell coated with immobilized 
oligonucleotides. These oligonucleotides then hybridize to the adapters attached to the 
DNA fragments (Hodkinson and Grice, 2015). Bridge amplification of each DNA 
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fragment results in the creation of a cluster that includes thousands of copies of the DNA 
fragment (Voelkerding et al., 2009; Liu et al., 2012). After cluster generation, the CRTs 
sequence the cluster of DNA fragments. The CRT sequencing uses reversible terminator 
(RT) nucleotides to terminate DNA synthesis temporarily after single nucleotide 
incorporation. These RT nucleotides are fluorescently labeled and contain a blocking 
group at the 3' hydroxyl (OH) molecule of the ribose sugar that allows one single base to 
be incorporated each cycle (Mardis, 2013). All four fluorescently labeled dNTPs 
(nucleotides) and polymerase are added to the flow cell and then nucleotides are added 
sequentially and detected by the presence of a unique fluorescent dye on each nucleotide 
(Corney and Basturea, 2013). With RT nucleotides, a single nucleotide is incorporated 
per sequencing cycle (Corney and Basturea, 2013; Ambardar et al., 2016). Nucleotide 
incorporation results in the production of a fluorescent signal, which is visualized by a 
camera. Hence, DNA base composition is identified via fluorescent dyes (Egan et al., 
2012). The Illumina error rate per base across all systems is ≤ 0.1 percent (Glenn, 2011). 
However, each Illumina system results in different read lengths, a yield of data per run, 
cost, and run time (www.illumina.com/systems/sequencing-platforms.html). For instance, 
the HiSeq 2000 system generates 2 × 150 base pair reads with 600 Gb of data per run in 
11 days (Quail et al., 2012), although one main concern of this system is the high 
computation needs (Glenn, 2011) to handle large amounts of data. The newest version of 
HiSeq systems 3000/4000 is improved to provide more rapid and higher performance 
sequencing of over 200 Gb per a day (Illumina, 2014).  
The Roche 454 technology relies on emulsion PCR and pyrosequencing chemistry 
(Mardis, 2008; Voelkerding et al., 2009; Siqueira et al., 2012). A DNA library is 
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constructed by fragmentation of genomic DNA (for genome sequencing) or cDNA (for 
RNA-seq). These DNA fragments undergo adapter ligation where adapters are added to 
both ends of the DNA fragments and then separated into single-stranded DNA (ssDNA) 
(Siqueira et al., 2012). The emulsion amplification process is initiated by immobilization 
of the ssDNA library onto DNA capture beads (one fragment per bead) (Hodkinson and 
Grice, 2015). Beads with the attached ssDNA and PCR reagents are emulsified in oil to 
form a water-in-oil microreactor (Lin et al., 2008; Radford et al., 2012). Ideally, each 
microreactor contains one bead along with one DNA fragment. The emulsion is then 
subjected to amplification by which the DNA fragment is amplified to generate 
monoclonal DNA beads (Radford et al., 2012). Clonally amplified beads are added into 
wells of a picotiter plate with a set of sequencing enzymes including DNA polymerase, 
ATP sulfurylase, and luciferase. The pyrosequencing reaction is initiated by sequential 
addition of four nucleotides (dNTPs) into the picotiter plate. Nucleotide incorporation 
results in pyrophosphate release and then ATP sulfurylase enzyme converts 
pyrophosphate to adenosine triphosphate (ATP). This ATP is used by the enzyme 
luciferase to convert luciferin to oxyluciferin that generates light signals that are detected 
by a camera to identify the base incorporated into a DNA fragment (Lin et al., 2008; 
Voelkerding et al., 2009; Hodkinson and Grice, 2015). The major strengths of the Roche 
454 technology are long read length and high-speed (Meldrum et al., 2011; Liu et al., 
2012). The latest 454 GS FLX system generates approximately one million reads per run 
(Hodkinson and Grice, 2015) in seven hours (Jazayeri et al., 2015). The read length of 
this system can reach 700 bp with 99.9% accuracy (Lin et al., 2008). The main 
limitations of the system are the high cost of reagents per MB ($7) and run ($6200) 
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(Glenn, 2011) and homopolymer errors (Meldrum et al., 2011), which are a number of 
miscalled bases that occur because of consecutive repetitions of a single nucleotide in a 
sequence (Fakruddin et al., 2012). Unfortunately, as of this writing the company has 
ceased operations but one may still find applications of this sequencing technology in the 
literature. 
The Applied Biosystems SOLiD (Sequencing by Oligonucleotide Ligation 
Detection) technology uses emulsion PCR that is similar to the Roche 454 technology 
(Dhiman et al., 2009) and di-base probes to perform sequencing by ligation (Roy et al., 
2016). The library preparation involves fragmentation of genomic DNA or cDNA by 
sonication, followed by ligation of adapters to both ends of these fragments 
(Yegnasubramanian, 2013). A water in oil emulsion PCR is performed to amplify the 
DNA fragments attached to polystyrene beads (Simon et al., 2009). The beads containing 
clonally amplified DNA fragments (template) are deposited onto a glass slide for 
sequencing (Dhiman et al., 2009). The ligase-mediated sequencing starts by annealing a 
complementary sequencing primer to the adapters on the amplified fragments (Mardis, 
2008; Daniels et al., 2012), and then a pool of four di-base probes that are fluorescently 
labeled are added into the flow cell, where they compete for ligation to the sequencing 
primers (Vogl et al., 2012). The probe is 8 nucleotides in length (Zhang et al., 2011), and 
consists of two known bases and six degenerate bases (Ambardar et al., 2016). Each 
probe is linked with one of four fluorescent labels at its 5' end and contains ligation and 
cleavage sites (Mardis, 2008; Voelkerding et al., 2009). The ligation site is at the 3' end 
of the di-base probe that hybridizes to the DNA template-primer and DNA ligase 
immobilizes the complex. The cleavage site is between the 5th and 6th base, which is the 
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position where a cleavage agent (e.g. silver) cleaves the last three bases and fluorescent 
dye from the probe. The 5' end of unexpended fragments is capped with phosphatase 
treatment. Phosphatase prevents any further ligation to maintain sequencing cycles 
(Goodwin et al., 2016). Following each ligation cycle, the fluorescent reporter is removed 
from the ligated probes, and the fluorescent signal is detected to determine the bases 
incorporated into the target sequence. A benefit of the SOLiD technology is high 
accuracy due to the two base sequencing approach (Liu et al., 2012). However, the 
limitation of the SOLiD technology is short read assembly (Hodkinson and Grice, 2015). 
The SOLiD 5500xl system generates 30 Gb per run with 99.99% accuracy and 85 bp read 
length in seven days (Liu et al., 2012). 
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Application of RNA-seq in livestock 
 In recent years livestock including cattle, swine, poultry, sheep, and goats have 
undergone considerable genome annotation by RNA-seq. Analysis of the livestock 
transcriptome is important for understanding gene function and improving livestock 
health and performance. Nowadays, researchers can sequence the whole transcriptome at 
a relatively low price in a short time. A major focus of the discipline of animal breeding 
and genetics is the selection of genetically superior animals for economically relevant 
traits. A genetic tool like RNA-seq may make identifying genetically superior animals 
more effective and less challenging (Bai et al., 2012). Below are some common 
applications that are used to investigate the transcriptome of livestock with RNA-seq. 
What follows is not a comprehensive assessment of livestock studies using RNA-seq.  
Instead, the focus is on how RNA-seq can be applied to answer different research 
questions in the animal sciences. 
Quantifying gene expression has been the most common RNA seq application. 
Many studies have compared the abundance of transcripts between experimental 
treatments and different breeds, production levels, and time courses. For example, the 
first study of marbling formation in snow dragon beef cattle (Chinese cattle breed) was 
performed using RNA seq; transcripts from adult beef longissimus dorsi (LD) muscle 
were sequenced in these cattle (Chen et al., 2015). The muscle samples were collected 
from animals (same age, genetic background, and under similar conditions) immediately 
after slaughter. These samples were scored for marbling and cattle with high and low 
marbling scores were identified. Approximately 13 Gb raw paired-end reads were 
generated. Among 16,020 analyzed genes, 749 genes showed differential expression 
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between the two groups (383 genes up-regulated in the low marbling group and 366 up-
regulated in the high marbling group) and were identified as putative candidates linked to 
marbling formation in LD muscle. This experiment is a good example of how RNA-seq 
can be used to identify transcriptomic differences between animals with differing levels 
of production. 
In another study, transcript differences were compared between four different 
tissues in the longissimus dorsi (LD) of adult cattle (Lee et al., 2014). The four tissues 
were muscle, intramuscular adipose (IMA), subcutaneous adipose (SUA), and omental 
adipose (OMA). The tissue samples were collected from the LD section of nine Hanwoo 
cattle (3 bulls, 3 steers, and 3 cows) under same condition and diet, immediately after 
slaughter. The average number of raw reads from each tissue was 34.2 Mb for muscle, 
35.8 Mb for IMA, 35.1 Mb for SUA, and 38.1 Mb for OMA. After data analysis, 7,282 
differentially expressed genes were identified among the four tissues. They found an 
inverse correlation between muscle and adipose tissues in gene expression patterns, such 
that genes that were up-regulated in muscle were down-regulated in other tissues, and 
vice versa. The IMA tissue exhibited district pattern of gene expression from SUA and 
OMA tissues. However, gene expression pattern of SUA and OMA tissues were similar. 
They concluded that intramuscular adipose tissue can be essential for regulation of 
structure and development of the LD tissues and for communication between muscle and 
adipose. This manuscript is a good example of the use of RNA-seq to better understand 
biological pathways expressed in different tissue types.  
The study of gene expression is not limited to bovine, but also includes other 
livestock species including chickens, pigs, horses, goats, and sheep. For instance, Wang 
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et al. (2014) used RNA seq to compare transcripts and signaling pathways associated 
with resistance to Avian Influenza Virus (AIV) infection between two chicken lines 
(Fayoumi and Leghorn). The two lines were genetically distinct in susceptibility to AIV 
infection with the Fayoumi line being more resistant than the Leghorn line. One group of 
chickens (n=2) from each line was inoculated with AIV (infected group) at 3 weeks of 
age and compared with controls (non-infected birds) from each line. Lungs and trachea 
samples were collected from 8 chickens (2 birds per treatment-by-line combination) at 4 
day post-inoculation. Total RNA from the samples was isolated to examine the AIV 
replication using real-time RT-PCR, and then to construct cDNA library for 
transcriptome sequencing. Virus replication was detected in all infected birds while virus 
replication was negative in control birds. Virus titers were also significantly higher in the 
Leghorn line than the Fayoumi line. Sequencing generated approximately 29.6 M and 
28.1 M reads for infected and non-infected Leghorn, respectively, and 28.7 M and 28.8 
M reads for infected and non-infected Fayoumi, respectively. Under AIV inoculation, 
117 genes were differentially expressed between the two lines. Only 6 of these genes 
were highly expressed in Fayoumi birds. Five of these genes were associated with the 
hemoglobin family, indicating a putative role of hemoglobin family genes in resistance to 
AIV infection. The authors concluded that up-regulation of hemoglobin family genes and 
down-regulation of cell adhesion molecules (CAMs) were highly correlated with disease 
resistance to AIV. Their results may be useful for understanding the molecular process of 
AIV infection and for development of new vaccines in poultry. 
Another RNA seq application is the identification of long noncoding RNAs 
(lncRNAs) that play a regulatory role in different biological processes. These lncRNAs 
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are non-coding transcripts that are more than 200 nucleotides in length (Perkel, 2013). 
This class of transcripts was known before next-generation sequencing approaches 
became available. Nevertheless, the extent of their existence was not completely 
understood until the RNA seq technique was able to discover the diversity of lncRNA 
species inside living organisms (Ilott and Ponting, 2013). In a recent study, differentially 
expressed lncRNAs from endometrium tissues of 3 pregnant and 3 non-pregnant Duroc 
gilts were analyzed using RNA seq (Wang et al., 2017). Samples were collected from 
both groups on day 12 of pregnancy. After total RNA isolation, libraries for lncRNA 
sequencing were prepared. A total of 1490 lncRNAs were identified. Thirty-four 
differentially expressed lncRNAs were identified between pregnant and non-pregnant 
pigs, of which 29 lncRNAs were up-regulated in pregnant sows while the remainder was 
down-regulated in pregnant sows on day 12 of pregnancy. The study identified two up-
regulated lncRNA loci that may be vital for embryo implantation. This experiment is a 
good example of the use of RNA-seq in identifying transcriptomic changes in non-coding 
RNA species. 
RNA seq has also been used to identify small noncoding RNAs. Small RNAs are 
20 to 30 nucleotides in length and include different types such as microRNAs (miRNAs) 
and piwi-interacting RNAs (piRNAs) (Großhans and Filipowicz, 2008). These small 
RNAs have an essential regulatory role in the maintenance and transcriptional gene 
silencing during spermatogenesis (De Mateo and Sassone-Corsi, 2014). In a recent study, 
Capra et al. (2017) compared miRNA and piRNA expression from semen of four 
Holstein bulls. For each bull, 12 semen samples were obtained and then grouped into 
high and low motile sperm fractions. The high and low fractions were evaluated for 
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sperm characteristics such as motility, viability, and acrosomal status; three replicates per 
fraction per bull were used to isolate total RNA. Small RNA libraries were prepared for 
sequencing. A total of 110,394,322 reads were obtained after trimming and 79 putative 
piRNAs and 83 miRNA clusters were differentially expressed between the high and low 
motile sperm. Among the DE miRNAs, 40 had been previously identified while the 
remainder had not. Among the known miRNAs, 26 were highly expressed in high motile 
fractions and the remainder (14) were highly expressed in low motile sperm. Some DE 
miRNAs in the high and low fraction targeted gene pathways related to apoptosis and 
alteration in spermatogenesis, and three pathways were found to be highly affected by 
dysregulation of these miRNAs. The authors concluded that based on specific DE 
miRNAs in the high versus low motile sperm, low motile sperm exhibited evidence of 
increased cell apoptosis and changes in cell function. It is clear that RNA-seq can be a 
useful application for many types of RNAs. 
Single nucleotide polymorphisms (SNPs) can be detected by RNA-seq. A SNP is 
a single nucleotide change at a locus in the genome. SNPs can act as a molecular marker 
that predicts genetic merit because of their linkage disequilibrium with causative 
polymorphisms. In a recent study, RNA seq was applied to Milk Somatic Cells (MSCs) 
from two sheep breeds (Churra and Assaf used in Spain) to detect genetic variants within 
coding regions associated with milk production traits such as milk yield, and fat and 
protein percentage (Suárez-Vega et al., 2017). Milk samples were collected from eight 
ewes (both breeds) at four lactation time points: 10, 50, 120, and 150 days post-lambing.  
Milk samples were collected for the recording of milk production traits (milk somatic 
cells for DNA isolation only need to be collected once). After RNA isolation and library 
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preparation, samples were sequenced. A total of 216,637 variants from > 1,116 M paired-
end reads were detected. Among these variants, 57,795 variants were identified within 
Quantitative Trait Loci (QTL) regions related to milk traits, 78.56% of which were 
known variants and 21.44% of which were novel variants. These SNPs might be used as 
potential markers for genetic prediction in the dairy sheep industry. This experiment is a 
good example of how RNA-seq can be utilized for discovery of genetic variants. 
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Conclusion 
 The above studies illustrate the power of RNA seq to identify genes and pathways 
associated with biological differences in livestock. Our study investigated changes in the 
whole blood transcriptome of beef cattle after vaccination with a commercially available 
Salmonella SRP vaccine. Our focus will be on changes in mRNA molecules in whole 
blood after vaccination. To date, we could not find published research that investigated 
how the transcriptome changes in response to this vaccine. The analysis of gene 
expression after vaccination could allow for discovery of newly discovered transcripts, 
novel functions of known transcripts, and putative gene-gene interactions.  
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Chapter 2 
Using RNA Seq to Define Genes and Pathways Affecting Salmonella 
Vaccine Response in Beef Cattle 
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Introduction 
 Vaccination prevents a wide range of bacterial and viral diseases that result in 
economic losses to livestock producers and decreased yield, fertility, morbidity, and 
mortality in beef and dairy cattle. For example, pre-calving vaccination of dams with a 
killed S. Typhimurium vaccine deceased calf mortality by 75% in calves challenged with 
Salmonella typhimurium (Jones et al., 1988). Vaccination of livestock may also be useful 
for protecting humans against zoonotic diseases like salmonellosis. It is estimated that 
each year Salmonella (nontyphoidal) causes an average of one million illnesses and 380 
deaths in the United States (Scallan et al., 2011). Therefore, advances in livestock 
vaccine programs against Salmonella species can aid in the decrease of disease incidence 
in humans. 
 Salmonella Newport Bacterial Extract vaccine with siderophore receptor and 
porin protein (SRP) technology is a vaccine that cattle producers can employ to control 
salmonellosis and reduce shedding of Salmonella in feces. This vaccine works by 
stimulating immunity to create antibodies that target bacterial siderophore and porin 
proteins. These proteins are found on the bacterial cell membrane and scavenge iron 
present in the body of infected animals. The vaccine impairs the iron uptake system by 
producing antibodies that block entry of iron into Salmonella through SRPs. Because iron 
is essential for survival of Salmonella, the bacterial cells begin to die (Thomson et al., 
2009).  
   To the extent of our knowledge, no study of the host genetic response to 
Salmonella SRP vaccination has been reported in beef cattle. Understanding how the host 
responds to vaccination is important for developing more effective vaccines that protect a 
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larger fraction of a population. One approach for studying the host genetic response 
involves transcriptome profiling by RNA-seq. Unlike microarrays, this approach does not 
require us to define the genes we want to examine before initiation of the experiment.  
With RNA-seq, we can investigate biological pathways affected by vaccination 
independent of whether we know the sequence or biological function of the gene. Our 
hypothesis was that vaccination of beef cattle with Salmonella SRPs would change gene 
expression in whole blood at 21 days and 48 days post-vaccination. Therefore, the 
objectives of the study were to identify differentially expressed genes and pathways in 
whole blood after vaccination with Salmonella SRPs and generate a list of candidate 
genes important for mounting an immune response to this vaccine in beef cattle.  
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Material and Methods 
Animal and Sample Collection 
 A total of five cows were sampled. All animals were Black Angus, born in 2011, 
housed at the SDSU Cow/Calf Research and Teaching Unit, and had never been 
immunized with Salmonella SRP vaccine. The cows were administered with 2 mL of 
Salmonella Newport SRP vaccine subcutaneously according to the manufacturer's 
instructions (http://www.epitopix.com/prod-cattle-salmonella). Blood samples were 
collected at three time points: time of the initial vaccination (day 0), time of booster 
vaccination (day 21), and 27 days after booster (day 48). Blood was collected in 
PAXgene tubes because the tubes provide an immediate stabilization of RNA after the 
blood is collected. The same five cows were used at all three time points, resulting in a 
total of fifteen blood samples. These samples were stored at -80 °C prior to RNA 
extraction.  
RNA Extraction 
Total RNA was isolated from all blood samples using the PAXgeneTM Blood 
RNA kit (PreAnalytiX, Qiagen, BD, Germany) according to the manufacturer’s 
instructions (Appendix A). Concentration and purity of RNA samples were assessed 
using a Nanodrop ND-1000 spectrophotometer (Thermo Scientific, Waltham, MA). 
Before constructing RNA seq libraries, the integrity of each RNA sample was evaluated 
with an Agilent Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA). 
 
Library Preparation and Sequencing 
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 The RNA samples with dry ice were submitted to LC Sciences (Houston, Texas 
USA) for library construction and sequencing. Samples were prepared using the 
Illumina® TruSeq Stranded Total RNA Library PrepKit (Illumina, San Diego, CA) 
following the manufacturer’s instructions. In the initial step of library preparation, 
polyadenylated RNA was isolated from the total RNA with poly (T) oligonucleotides 
attached to magnetic beads and then fragmented using divalent metal cations under high 
temperatures. First strand cDNA synthesis was performed using random primers and 
reverse transcriptase followed by synthesis of second strand cDNA to generate double-
stranded cDNA. To form blunt ends, ds cDNA was subjected to end repair followed by 
addition of an adenine (A) nucleotide to the 3' ends. Adapters were ligated to the ends of 
the cDNA fragments followed by solid-phase PCR amplification to produce the 
sequencing library. Each sequencing library was indexed with a distinct adapter and was 
assessed for quality using an Agilent 2100 Bioanalyzer. The indexed library samples 
were normalized and pooled in equimolar concentrations prior to sequencing. Single-read 
sequencing (150 cycles) was performed on a single-lane flow cell of an Illumina HiSeq 
2000 system using the HiSeq SR (Single Read-150 bases) Cluster Kit v4 at LC Sciences 
(Houston, Texas). 
Processing of raw data 
The raw sequencing reads were stored as fastq files, including the read summary 
of each sample. With the FastQC software 
(https://www.bioinformatics.babraham.ac.uk/projects/fastqc/), the quality of the reads 
was assessed to determine sequencing errors, contamination, and sequencing or PCR 
artifacts. Reads with low quality score and length less than 10 bp were removed. Also, 3' 
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adapter sequence and repetitive elements were trimmed using Cutadapt 
(https://cutadapt.readthedocs.io/en/stable/). After filtering, reads with length greater than 
10 bp were used for mapping to the bovine genome.  
Bioinformatics   
Bioinformatics analyses (except DAVID analysis; see below) were completed by 
LC Sciences (Houston, Texas, USA). The trimmed reads were aligned to the Bovine 
reference genome (Bta_4.6.1) using the Bowtie/Tophat_v2.0.12 (Trapnell et al., 2012; 
Kim et al., 2013) to identify transcripts. Tophat utilized Bowtie for alignment of cDNA 
sequencing reads against the virtual transcriptome build and then mapped the reads to the 
reference genome to extract transcript sequences. The resulting alignment was stored in a 
BAM file format (Li et al., 2009) and filtered for mismatched reads.  
  A filtered BAM file of the read alignments was submitted to Cufflinks v2.2.1 
(Trapnell et al., 2012) to assemble transcripts and estimate their abundance for each 
sample. Cufflinks first assigned genomic regions that were overlapped by sequencing 
reads as being potential exons and then utilized mapped junctions to assemble transcripts. 
The Cuffdiff module of Cufflinks was used for pairwise differential expression analysis 
at the gene level. In this process, the transcript abundance was normalized and evaluated 
in Fragments Per Kilobase of transcript per Million mapped reads (FPKM) (Mortazavi et 
al., 2008) using Cuffdiff. The FPKM values for all genes were used to estimate 
differential expression between samples at different time points. Tests for statistical 
significance (P-values) accounted for multiple testing by computing the False Discovery 
Rate p-value (FDR P-value) using the Benjamini-Hochberg correction (Benjamini and 
Hochberg, 1995). The FDR adjusts P-values for the number of hypothesis tests 
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performed to control type I error rate (proportion of false positives). Differences in 
expression were statistically significant when q-value (FDR adjusted P-value) was less 
than 0.05.  
Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) 
pathway analysis of the differentially expressed genes were completed by an online 
software called Database for Annotation, Visualization, and Integrated Discovery 
(DAVID) (Huang et al., 2009). DAVID is a bioinformatics resource containing 
an integrated biological knowledgebase and analytic tools that aim to systematically 
extract enriched biological and functional meaning behind a given list of genes or 
proteins with q-value (Benjamini) < 0.05. Initially, a list of gene IDs was imported into 
the Functional Annotation Tool of DAVID where the most relevant GO terms and KEGG 
pathways were identified. The GO terms are a set of structured and controlled 
vocabularies to describe attributes of genes and gene products based on three biological 
domains. These domains are shared by all organisms and consist of biological processes, 
cellular components, and molecular functions (The Gene Ontology Consortium, 2008). 
The KEGG pathways are a compilation of manually drawn diagrams displaying networks 
of molecular interaction and biochemical reactions in various cellular processes 
(http://www.genome.jp/kegg/pathway.html). Thus, the GO term category of DAVID 
matches the input gene lists to their corresponding biological terms while the KEGG 
pathway category represents the summary of enriched pathways that are over- and 
underrepresented among differentially expressed genes.  
Real Time RT-PCR 
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 To validate differentially expressed genes from sequencing results by the real-
time reverse transcription polymerase chain reaction (RT-PCR) method, candidate genes 
were selected based on the following criteria: 1) presence of detectable expression across 
all three time points and 2) fold change > 2 between day 0 and day 48 samples. 
Performing the real-time RT-PCR reaction was only possible with RNA samples from 
two time points: day 0 and day 48. Day 21 samples were excluded because sufficient 
RNA was not available from samples at this time point. For both selected genes and a 
reference gene, a pair of primers (forward and reverse) was designed using the 
PrimerQuest Tool from Integrated DNA Technologies (https://www.idtdna.com). 
Initially, the mRNA sequence of each gene was retrieved as a FASTA file from the 
National Center for Biotechnology Information (NCBI) (https://www.ncbi.nlm.nih.gov/). 
Then, the FASTA file for each gene was submitted to the UCSC Genome Browser 
(https://genome.ucsc.edu) where the BLAST-like alignment tool (BLAT) was used to 
align the mRNA sequence to the genome. Mapping the mRNA sequences to the genome 
with BLAT allows identification of exon-intron boundaries. Primers designed in 
PrimerQuest were mapped to the bovine genome to ensure primers overlapped at least 
one exon-intron boundary. All primer sets were ordered from Integrated DNA 
Technologies. Before resuspending dry oligonucleotides in water, the tubes were briefly 
centrifuged to collect the oligo pellets at the bottom of tubes. A resuspension calculator 
(https://www.idtdna.com/Calc/resuspension/) was used for calculating the volume needed 
to resuspend the oligonucleotides to the desired concentration that was based on the 
quantity and molecular weight of the oligo and final concentration desired (400μM).  
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 Prior to real-time RT-PCR, an equal quantity of RNA from each sample was 
pooled to create a standard curve. The reason for performing the standard curve (1:2 
dilution series) was to estimate the efficiency of the primer pair during PCR. Real-time 
RT-PCR was performed using the iTaq™ Universal SYBR® Green One-Step Kit (Bio-
Rad, Hercules, CA) including iTaq universal SYBR® Green reaction mix (2x) and iScript 
reverse transcriptase. The 10 μl reaction setup was prepared by adding all required 
components according to the manufacturer's recommendations (Appendix B). The PCR 
plate was loaded into a MxPro3005P real-time thermocycler (Agilent Technologies, 
Santa Clara, CA) and was programmed as follows: reverse transcription reaction at 50 °C 
for 10 minutes; polymerase activation and DNA denaturation at 95°C for 1 minute; and 
40 cycles of amplification including denaturation at 95°C for 15 seconds and the 
annealing/extension step at 60°C for 30 seconds. A melt-curve was generated by 
increasing the temperature by 0.5°C every 5 seconds from 65°C to 95°C. Forward and 
reverse primers for each gene are provided in Table 2.1. Glyceraldehyde-3-Phosphate 
Dehydrogenase (GAPDH) was used to normalize expression levels among samples. 
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Results 
 In the present study, day 0 (time of initial vaccination) was our control group. We 
chose day 0 as our control because vaccination would not have affected gene expression 
at this time point. Day 0 was compared with day 21 and day 48 after immunization to 
identify DE genes and to determine changes in the expression patterns of each gene at all 
time points.  
 The raw number of reads obtained for each sample ranged from 2 198 017 to 12 
890 843 million single-end fragments (one read per fragment), amounting to a total of 
151 709 746 million reads for the entire experiment. Additionally, the overall rate of read 
alignment to the bovine genome attained by TopHat ranged between 93.7 to 98.9% 
(Table 2.2). This data indicated a high consistency between samples for the number of 
and proportion of mapped reads. 
 Cufflinks analysis revealed a total of 848 genes that differed significantly in 
expression in whole blood (q-value <0.05) at 21 days after vaccination. Five hundred and 
eleven of the DE genes were increased in abundance and the remaining 337 genes were 
decreased in abundance relative to day 0. At day 48 post-vaccination, 1155 genes were 
differentially expressed (q-value <0.05), of which 922 were increased in abundance while 
the remaining 234 genes were decreased in abundance. Further analysis of the increased-
and decreased in abundance genes was carried out for genes that were both differentially 
expressed and had a fold-change ≥ 2 and ≤ 2, respectively. The median FPKM of the five 
samples at each time point was used to compute the fold change. This further analysis 
identified one increased in abundance gene at day 21 post-vaccination (Table 2.3) and 26 
decreased in abundance genes at this same time point (Table 2.5). At day 48, 20 genes 
 50
were increased in abundance (Table 2.4) and 39 genes were decreased in abundance 
(Table 2.6) with fold-change ≥ 2 and ≤ 2, respectively, relative to day 0. In total, 22 
decreased in abundance genes were differentially expressed at both day 21 and day 48 
post-vaccination.  
Gene ontology analysis completed by DAVID for genes found in the comparison 
of 1) day 21 samples vs. day 0 samples and 2) day 48 samples vs. day 0 samples 
identified a list of significant decreased and increased in abundance GO terms ( adjust P-
value< 0.05) and revealed enriched functionally-related gene sets. The genes included in 
biological process clusters for both days 21 and 48 were associated with functions 
including heme biosynthetic process and protoporphyrinogen IX biosynthetic process. 
The list of genes involved in the heme biosynthetic process was ALAD, HMBS, 
SLC25A39, ATPIF1 and ALAS2 (Table 2.7). Interestingly, hemoglobin binds to iron in 
the bloodstream and antibodies generated by the vaccine block iron entry into Salmonella 
(Thomson et al., 2009). All five DEG genes that are components of the heme biosynthetic 
pathway were decreased in abundance at day 21 and day 48 (Figure 2.1). The cellular 
component cluster at day 21 included genes involved in cytoplasm and membrane. While 
none of the cellular components was found at day 48. Finally, the genes in a molecular 
function cluster for day 21 were related to DNA helicase activity, while no significant 
molecular function cluster for day 48 was identified. The increased in abundance GO 
terms for day 21 and day 48 were involved in a wide range of general biological 
processes and molecular activity which were less likely to be directly related to a vaccine 
response. Therefore, we focused on the decreased in abundance genes present in these 
clusters.  
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 Three decreased in abundance pathways were identified by KEGG pathway 
analysis at day 21 post-vaccination including the FoxO signaling pathway (Figure 2.2), 
AMPK signaling pathway, and porphyrin and chlorophyll metabolism (Table 2.9). 
Significant pathways found decreased in abundance at day 48 post-vaccination were 
porphyrin and chlorophyll metabolism, Staphylococcus aureus infection, prion diseases, 
and chagas disease (American trypanosomiasis). Increased in abundance pathways for 
day 21 relative to day 0 included pathways affecting the ribosome, oxidative 
phosphorylation, and spliceosome, while for day 48 relative to day 0 were the FoxO 
signaling pathway and NOD-like receptor signaling pathways. Other significantly 
increased in abundance pathways at day 48 were involved in endocytosis, chronic 
myeloid leukemia, hepatitis B and hepatitis C.  
 Real-time RT-PCR results were analyzed with the Relative Expression Software 
Tool (REST). REST is a software package designed to analyze gene expression from 
real-time RT-PCR amplification data, and then determines statistical significance 
between samples and controls. It also takes into account differences in PCR efficiency 
and normalizes results to reference gene(s) (Pfaffl et al., 2002). The GAPDH reference 
gene was used to normalize samples, and the comparison was between day 0 and day 48 
samples. The genes that were tested are ALAS2, ATPIF1, and HMB. All these genes 
were decreased in abundance (same direction as for RNA-seq) and statistically significant 
between day 0 and day 48 (Table 2.8). 
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Discussion 
The ability of RNA-seq analysis to uncover patterns of expression across the 
whole genome allows an investigation of a wide range of genes in an experiment. As a 
large number of genes are explored, the number of differentially expressed genes 
associated with the same biological function can be determined. Nevertheless, 
interpretation of the data can be challenging. Our study uncovered differentially 
expressed genes that were increased and decreased in abundance in whole blood at 21 
days and 48 days post-vaccination with Salmonella SRP vaccine with a fold change ≥ 2. 
Although we expected to observe more increased in abundance genes and pathways after 
vaccination, a decrease in abundance of genes was a predominant trend in this study and 
occurred in all five animals. One gene was increased in abundance and 26 genes were 
decreased in abundance (fold-change ≥ |2|) at day 21 relative to day 0 in all samples. The 
following sections are a discussion of some of the decreased in abundance genes and 
pathways identified in this experiment as well as the potential role of SRP vaccination 
against Salmonella. 
A decrease in abundance of genes and pathways in our study could be due to 
several reasons. The first reason is lack of vaccine efficacy to stimulate a strong immune 
response after vaccination. Previous studies indicated that antibody concentration in 
blood serum of vaccinated dairy cattle with Salmonella SRPs were significantly higher 
(P-value = 0.01) than non-vaccinated cattle (Hermesch et al, 2008; Smith et al., 2014). 
These studies provide evidence of the vaccine’s effectiveness in eliciting an immune 
response against Salmonella bacteria, but the vaccine might not produce a strong enough 
immune response to cause an increase in abundance of immune response genes in whole 
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blood at the times examined in this study. This vaccine is an inactivated vaccine that can 
stimulate only the humoral response and requires adjuvants and multiple doses to provide 
long-lasting immunity to animals. Another possible reason for the lack of an increase in 
abundance of genes related to the immune response is that cattle are reservoirs for 
Salmonella species, indicating Salmonella Newport SRPs. Therefore, these SRPs might 
not be strongly recognized as a foreign antigen by the host.  
However, with regard to a genetic response to Salmonella SRP vaccine as 
measured by deep sequencing techniques, equivalent studies have not been conducted. 
Similar to our experiment, a previous study demonstrated a potential for whole blood 
transcriptome profiling by RNA seq to identify immune-related biomarkers. This study 
found that most DE genes were up-regulated in dairy cattle following vaccination 
(Demasius et al., 2013). However, this group used a viral antigen to stimulate immunity 
while we used a bacterial antigen. Response to an antigen can vary depending on 
pathogen types and how an antigen is prepared. Another study of whole blood 
transcriptome profiling with a microarray explored bovine immune response after a 
bacterial challenge (Rodrigues et al., 2015). Interestingly, consistent with our results, they 
found that the majority (84.9%) of DE genes and pathways were down-regulated 
(decreased in abundance), including pathways involved in the lymphatic system and B-
lymphocytes. 
Five decreased in abundance genes (ALAD, HMBS, SLC25A39, ATPIF1, and 
ALAS2) in our study were highly associated with heme and porphyrin-containing 
compound biosynthetic process. A decrease in abundance of these genes might be due to 
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the host immune response to Salmonella SRP antigen. Gram-negative bacteria like 
Salmonella enterica utilize numerous iron storage and transport proteins (e.g. host heme, 
transferrin, siderophores) to fulfill its nutritional need for iron (Krewulak and Vogel, 
2008). Most of the iron inside a host is found within heme proteins, specifically 
hemoglobin (Burman, 1974). Siderophore receptors enable Salmonella to extract iron 
from their environment as iron is required for bacterial metabolism (Neilands, 1995). The 
SRP vaccine produces sufficient antibodies that target Salmonella siderophore receptors, 
preventing transport of iron molecules into the bacteria. One possibility is that the 
vaccine has pleiotropic effects on genes related to iron uptake in the host. 
It is possible that the SRP vaccine was not responsible for a decrease in 
abundance of these genes, and instead other factors such as the environment, different 
pathogens, or diets could be causing these changes in gene expression. However, the only 
known change in the animals’ environment during the study period was the 
administration of the Salmonella SRP vaccine. Animals’ diet was not changed and no 
disease was reported during the entire experiment. Still, we cannot rule out the possibility 
that an unknown environmental effect may have caused some of the changes observed in 
gene expression. It is important to mention that more immune-related genes and 
pathways could have been detected in the present study if peripheral blood mononuclear 
cells have been used instead of whole blood. Transcriptome analysis of whole blood 
captures changes in gene expression among all red and white blood cells (including 
neutrophils), while PBMCs focus on only changes in lymphocyte and monocyte gene 
expression. 
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All five DE genes related to heme biosynthesis process in our study were 
previously found to affect heme biosynthesis using microarrays (Nilsson et al., 2009). 
Zebrafish was used as an in vivo vertebrate to identify genes that are required for 
functional heme biosynthesis in red blood cells. They found that the SLC25A39 enzyme 
is required for proper hemoglobin synthesis. Their results support a major role of 
SLC25A39 in the regulation of heme levels and maintenance of mitochondrial iron 
homeostasis. The ALAD enzyme catalyzes the second step in the heme biosynthetic and 
porphyrin pathway (Kelada et al., 2001) and plays a major role in lead toxicity in blood 
(Behera et al., 2016). The HMBS enzyme catalyzes the third step of the heme 
biosynthetic pathway (Ulbrichova et al., 2009), and is highly associated with an inherited 
disorder called porphyria, which is caused by abnormal heme production (Bustad et al., 
2013). The ALAS2 gene has an essential role in the formation of hemoglobin by 
erythroid cells (Whatley et al., 2008). ATPIF1 modulates heme synthesis during 
differentiation of erythroid cells (Shah et al., 2012). 
Siderophores are small molecules used by microbes to scavenge iron from a host 
and are considered a major virulence factor during infection with bacteria. Sassone-Corsi 
et al. (2016) demonstrated that immunization of mice with siderophore protein conjugates 
(derived from cholerae bacteria) induced an antibody response against siderophores and 
resulted in reduction of the intestinal and systemic colonization of Salmonella enterica. 
The authors concluded that the immunogenic carrier protein could be a potential tool to 
limit microbial burden and reduce the outcomes of infection. Similar to the previous 
study, Cox et al. (2017) used Salmonella enterica Enteritidis (SE) which is a siderophore 
receptor-porin vaccine in chickens. They found that the SE SRP vaccine was effective in 
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reduction of Salmonella shedding and prevention of reproductive tract colonization in 
vaccinated chickens.  However, other studies found that the SRP antigen (derived from 
Salmonella Newport) was not associated with Salmonella reduction in feces (Dodd et al., 
2011; Heider et al., 2008). One reason for conflicting results is Salmonella Newport SRPs 
might not be effective against all Salmonella serotypes in cattle (Cernicchiaro et al., 
2016). Another reason might be due to differences in digestive systems between 
mice/poultry and cattle. Cattle contain diverse microbial populations in their digestive 
tract compared with mice/poultry, which lack a rumen.  
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Conclusion 
In the present study, we investigated differentially expressed genes and pathways 
in whole blood of beef cattle after vaccination with Salmonella SRPs. We found that 
most DE genes and pathways were down-regulated rather than up-regulated at both time 
points (d21 and d48 post-vaccination). Genes in the heme biosynthetic process were 
down-regulated after vaccination. These genes play an important role in regulation of 
heme biosynthesis and metabolism. Several KEGG pathways were identified as well 
including AMPK and FoxO signaling pathways and the porphyrin metabolism pathway. 
This study could be a first step toward better understanding of the molecular mechanisms 
responsible for a vaccine response.  
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Table 2.1 Forward and Reverse Primers Used for Real-Time RT-PCR* 
Gene 
Symbol 
Gene Name Direction Primer Sequence PCR 
Efficiency 
Amplicon 
Length 
 
GAPDH Glyceraldehyde-3-Phosphate 
Dehydrogenase 
FWD 
REV 
5'- GAT GCT GGT GCT GAG TAT GT -3' 
5'- GCA GAA GGT GCA GAG ATG AT -3' 
94.7% 113bp 
  ALAS2 5'-Aminolevulinate synthase 2 FWD 5'- CTT GCC AGG GTG TGA GAT TTA -3’ 85.5% 107bp 
REV 5'- CAG GAT CAT TGT GCC TGA AGA -3’ 
ATPIF1 ATPase inhibitory factor 1 FWD 5'- TAC TTC CGA GCT CGT GCT AA -3'  70.0% 120bp 
REV 5'- CTG CTT ATG CCG CTC AAT TTC -3' 
 HBM Hemoglobin Subunit Mu FWD 5'- TCT TCA CTG TGT ACC CTA GCA -3' 95.9% 213bp 
REV 5'- GGA TCA CCA GTG GGA AGT TG -3' 
 
      * Real-time reverse transcription polymerase chain reaction 
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Table 2.2 Summary of Next Generation Sequencing Reads for each Sample 
 
Sample & Time Point Number of reads Number (%) reads mapped to bovine genome 
   
116—d 0 10 515 662 10 363 117 (98.55%) 
116—d21 9 617 720 9 417 720   (97.92%) 
116—d48 12 269 345 11 505 992 (93.78%) 
133—d0 11 037 438 10 879 003 (98.56%) 
133—d21 9 154 869 8 901 246   (97.23%) 
133—d48 10 773 153 10 446 866 (96.97%) 
140—d0 10 122 006 9 780 734   (96.63%) 
140—d21 7 303 897 7 217 419   (98.82%) 
140—d48 10 705 198 10 562 128 (98.66%) 
143—d0 9 423 631 9 303 833   (98.73%) 
143—d21 2 198 017 2 059 846   (93.71%) 
143—d48 12 470 610 12 095 478 (96.99%) 
148—d0 12 598 709 12 467 396 (98.96%) 
148—d21 12 890 843 12 716 807 (98.65%) 
148—d48 10 628 648 10 388 605 (97.74%) 
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Table 2.3 Differentially Expressed Genes Increased in Abundance at 21 Days Post-Vaccination with a Fold-Change ≥ 2 
 
FDR3-Adj          
p-value 
  FPKM4_D0 Numbers     FPKM_D21 Numbers 
ID1 Gene  FC2   Avg5  SD6     Avg5  SD6 
XLOC_000432 BT.89425 2.98 4.57E-02   0.25  0.22      1.39  1.2 
    1 Locus Identifier 
    2 Fold Change 
    3 False Discovery Rate  
    4 Fragments Per Kilobase of transcript per Million mapped reads  
    5 Average of five samples for day 0 and day 21, respectively. 
    6 Standard deviation 
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Table 2.4 Differentially Expressed Genes Increased in Abundance at 48 Days Post-Vaccination with a Fold-Change ≥ 2 
      
FDR3-adj          
p-value 
FPKM4_D0 Numbers FPKM_D48 Numbers 
ID1 Gene  FC2 Avg5 SD6 Avg5 SD6 
 XLOC_019465 DMBT1 3.86 1.60E-03 0.23 0.15 4.24 1.85 
XLOC_020745 ROBO3 3.54 1.60E-03 9.84 20.89 751.66 1231.57 
XLOC_024014 TNPO3 3.20 1.60E-03 34.34 39.98 140.93 138.47 
XLOC_003247 TPC3 3.19 1.60E-03 0.93 0.4 7.85 1.41 
XLOC_017235 C2 2.99 1.60E-03 7.26 3.22 55.25 14.53 
XLOC_012518 KRT10 2.78 4.14E-03 0.15 0.11 3.09 3.88 
XLOC_029167 BT.87687 2.68 1.60E-03 0.63 0.27 4.62 0.66 
XLOC_024940 C1R 2.65 1.60E-03 10.41 3.38 72.83 20.36 
XLOC_026254 BT.64790 2.61 1.60E-03 0.36 0.18 2.31 0.79 
XLOC_014106 ALPL 2.57 1.60E-03 6.37 6.37 23.03 11.99 
XLOC_021226 BT.88775 2.54 1.60E-03 3.33 1.28 21.68 8.85 
XLOC_022268 SLAMF8 2.43 5.24E-03 1.19 0.84 6.26 2.55 
XLOC_011764 bta-mir-10a 2.37 1.60E-03 301.34 507.32 1460.55 2379.98 
XLOC_022150 SPP2 2.34 1.60E-03 1.71 1.26 8.54 5.99 
XLOC_028332 GDF9 2.27 2.96E-02 0.08 0.04 5.03 10.77 
XLOC_018836 NUPR1 2.21 1.60E-03 24.74 7.23 144.55 59.76 
XLOC_009447 MN1 2.13 2.26E-02 0.30 0.09 1.33 0.49 
XLOC_018123 BT.66080,SERPINB4 2.09 8.95E-03 1.86 1.83 4.46 3.02 
 68
XLOC_020995 BT.40283 2.03 1.60E-03 0.59 0.42 2.59 1.11 
XLOC_006657 TEX12 2.01 1.07E-02 0.74 0.43 2.01 0.91 
 
    1 Locus Identifier 
    2 Fold Change 
    3 False Discovery Rate  
    4 Fragments Per Kilobase of transcript per Million mapped reads  
    5 Average of five samples for day 0 and day 48, respectively. 
    6 Standard deviation 
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Table 2.5 Differentially Expressed Genes Decreased in Abundance at 21 Days Post-Vaccination with a Fold-Change ≤ 2 
      
FDR3-Adj          
p-value 
FPKM4_D0 Numbers FPKM_D21 Numbers 
ID1 Gene  FC2 Avg5 SD6 Avg5 SD6 
XLOC_018239 HBM 8.21 1.15E-02 188.37 149.47 1.21 1.49 
XLOC_030110 ARG1 6.45 1.60E-03 11.84 8.39 0.21 0.11 
XLOC_029129 EPB49 6.07 1.60E-03 10.42 7.82 0.16 0.12 
XLOC_031117 BT.43709 5.91 1.60E-03 35.35 26.87 0.58 0.54 
XLOC_023921 AQP1 5.73 1.60E-03 3.31 3.07 0.65 1.09 
XLOC_027423 SEMA6B 5.65 2.50E-02 4.60 4.89 0.13 0.15 
XLOC_031733 ALAS2 5.32 1.60E-03 1551.37 1233.4 27.48 9.97 
XLOC_002105 EPB42 5.22 1.60E-03 10.22 7.062 0.40 0.31 
XLOC_002793 BT.57494 4.51 2.93E-03 2.75 2.048 0.12 0.09 
XLOC_029496 BT.67346 4.42 1.80E-02 3.59 1.87 0.11 0.07 
XLOC_006403 BT.49731 3.91 1.60E-03 76.23 39.94 4.88 1.94 
XLOC_027297 KLF1 3.74 1.60E-03 42.96 32.55 3.14 1.24 
XLOC_015638 BT.88457 3.47 1.60E-03 26.00 18.12 1.86 0.90 
XLOC_000110 ENSBTAG00000023666 3.44 1.60E-03 26.57 19.04 1.43 0.41 
XLOC_007905 TMCC2 3.23 1.60E-03 62.05 53.45 5.19 1.43 
XLOC_027545 TRIM58 3.05 1.60E-03 10.92 6.75 1.09 0.30 
XLOC_020086 DUSP26 3.01 2.93E-03 4.57 2.37 0.56 0.35 
XLOC_018657 TMEM8 2.80 1.60E-03 72.34 58.42 6.64 1.70 
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XLOC_014041 ATPIF1 2.79 1.60E-03 4734.68 4266.27 395.44 34.78 
XLOC_002859 CHAC2 2.51 1.60E-03 7.53 4.32 1.52 0.27 
XLOC_027205 PLVAP 2.44 1.60E-03 3.31 1.89 0.50 0.13 
XLOC_016056 IFRD2 2.32 1.60E-03 145.30 93.01 24.29 4.13 
XLOC_010349 TMEM86B 2.28 1.60E-03 34.34 27.32 4.87 1.60 
XLOC_027303 TNPO2 2.52 2.96E-02 126.70 121.08 65.12 105.27 
XLOC_005534 C20ORF123 2.17 3.18E-02 3.56 2.15 0.92 0.58 
XLOC_018530 WBSCR27 2.14 4.71E-02 4.94 5.23 0.68 0.47 
      
    1 Locus Identifier 
    2 Fold Change 
    3 False Discovery Rate  
    4 Fragments Per Kilobase of transcript per Million mapped reads  
    5 Average of five samples for day 0 and day 21, respectively. 
    6 Standard deviation 
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Table 2.6 Differentially Expressed Genes Decreased in Abundance at 48 Days Post-Vaccination with a Fold-Change ≤ 2 
 
    
FPKM4_D0 Numbers 
 
FPKM_D48 Numbers 
   FDR3-Adj              
ID1 Gene  FC2 p-value Avg5 SD6 Avg5 SD6  
XLOC_019406 BT.35938 12.20 1.60E-03 37215.74 37573.37 414.24 913.26  
XLOC_018239 HBM 6.58 5.24E-03 188.37 149.47 1.13 0.64  
XLOC_029129 EPB49 6.13 1.60E-03 10.42 7.82 0.16 0.09  
XLOC_031117 BT.43709 6.07 1.60E-03 35.35 26.87 0.74 0.59  
XLOC_031733 ALAS2 6.05 1.60E-03 1,551.37 1233.41 14.60 4.58  
XLOC_002911 REEP1 5.75 1.60E-03 8.05 5.39 0.12 0.04  
XLOC_030110 ARG1 5.66 1.60E-03 11.84 8.39 0.35 0.17  
XLOC_009241 GYPB 5.23 1.60E-03 8.06 6.74 0.36 0.34  
XLOC_002793 BT.57494 4.87 7.27E-03 2.75 2.05 0.07 0.03  
XLOC_023921 AQP1 4.69 1.60E-03 3.31 3.07 0.12 0.05  
XLOC_027743 bta-mir-378-1 4.32 1.60E-03 36766.80 57965.01 1544.26 2206.33  
XLOC_007613 ENSBTAG00000040320 4.17 2.73E-02 27.12 44.06 1.61 2.12  
XLOC_002105 EPB42 3.87 1.60E-03 10.22 7.06 0.97 0.56  
XLOC_006403 BT.49731 3.85 1.60E-03 76.23 39.94 5.57 1.38  
XLOC_015417 ENSBTAG00000048096 3.84 3.24E-02 4.31 2.92 0.55 0.66  
XLOC_027205 PLVAP 3.77 4.14E-03 3.31 1.89 0.20 0.14  
XLOC_027595 ELA2 3.43 1.60E-03 8.87 3.94 0.74 0.37  
XLOC_027297 KLF1 3.39 1.60E-03 42.96 32.55 3.59 0.28  
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XLOC_000110 ENSBTAG00000023666 3.23 1.60E-03 26.57 19.04 1.95 0.93  
XLOC_020086 DUSP26 3.12 1.60E-03 4.57 2.37 0.45 0.12  
XLOC_029153 ADAMDEC1 2.97 1.60E-03 13.52 10.34 1.00 0.67  
XLOC_010807 PGLYRP1 2.91 1.23E-02 6.67 4.23 1.01 0.48  
XLOC_002859 CHAC2 2.90 1.60E-03 7.53 4.32 1.47 0.57  
XLOC_015638 BT.88457 2.81 1.60E-03 26.00 18.12 3.94 2.26  
XLOC_026522 ZFYVE28 2.78 1.60E-03 56.77 15.41 11.48 8.73  
XLOC_010349 TMEM86B 2.72 1.60E-03 34.34 27.32 4.10 0.98  
XLOC_007905 TMCC2 2.52 1.60E-03 62.05 53.45 9.36 2.97  
XLOC_012151 ENSBTAG00000039504 2.43 2.93E-03 11.72 6.06 1.75 1.08  
XLOC_007611 PRG3 2.38 1.60E-03 19.42 25.65 1.85 1.66  
XLOC_018657 TMEM8 2.35 1.60E-03 72.34 58.42 7.26 0.83  
XLOC_014041 ATPIF1 2.33 1.60E-03 4734.68 4266.27 559.58 107.09  
XLOC_016056 IFRD2 2.25 1.60E-03 145.30 93.01 29.73 10.16  
XLOC_016871 BT.26590 2.17 1.60E-03 11.33 7.73 2.07 0.81  
XLOC_000819 MLF1 2.13 4.97E-02 1.52 0.97 0.36 0.12  
XLOC_027545 TRIM58 2.12 1.60E-03 10.92 6.75 2.12 0.53  
XLOC_018242 HBQ1 2.11 2.93E-03 19.34 18.55 1.81 0.69  
XLOC_016080 bta-mir-191 2.07 1.60E-03 4576.13 6988.25 878.88 1139.58  
XLOC_009397 SDSL 2.05 1.60E-03 11.46 3.99 2.47 1.02  
XLOC_013341 STRADB 2.00 1.60E-03 15.86 7.56 3.89 1.24  
 
1 Locus Identifier  2 Fold Change  3 False Discovery Rate  4 Fragments Per Kilobase of transcript per Million mapped reads                                
5 Average of five  samples for day 0 and day 48, respectively. 6 Standard deviation 
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Table 2.7 Heme Biosynthetic Process Genes Decreased in Abundance at 21 Days and 48 Days Post-Vaccination in All Samples 
 
                 
Gene Symbol  
                                                        
Gene name 
Log2 (FC)1 
day21 
Log2 (FC)1 
day48 
                                          
Adj P-value2 
ALAD Aminolevulinate dehydratase -1.24 -1.47 1.60E-03 
HMBS Hydroxymethylbilane synthase -1.46 -1.63 1.60E-03 
SLC25A39 Solute carrier family 25, member 39 -1.93 -1.75 1.60E-03 
ATPIF1 ATPase inhibitory factor 1 -3.58 -3.08 1.60E-03 
ALAS2 5'-Aminolevulinate synthase 2 -5.82 -6.73 1.60E-03 
 
   1 Fold Change 
   2 False Discovery Rate Adjusted P-value 
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Table 2.8 Validation of RNA-seq by Real-Time RT-PCR (d 48 vs. d 0 post-vaccination) 
 
 
 
 
 
 
 
 
 
 
   ALAS2           5'-Aminolevulinate Synthase 2 
   ATPIF1          ATPase inhibitory factor 1  
   HMB              Hemoglobin, mu 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gene 
 
Expression 
 
Std. Error 
95%Confidence 
Interval 
 
P-value 
 
ALAS2 0.016 0.005 - 0.052 0.004 - 0.068 0.002  
ATPIF1 0.244 0.092 - 0.475 0.072 - 0.553 0.014  
HMB 0.019 0.008 - 0.065 0.007 - 0.071 0.001  
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Table 2.9 Decreased in Abundance Pathways at Day 21 Post-Vaccination 
 
                                                                       
KEGG Pathway 
Adjusted 
p-values 
Gene    
Set-Size 
Genes 
FoxO signaling pathway  8.90E-03 11 BCL6, CREBBP, GABARAPL1, FOXO1, FOXO3, 
IGF1R, IRS2, PIK3CD, SGK1, SOD2, SOD2 
AMPK signaling pathway 1.20E-02 10 STRADB, ADIPOR1, CPT1A, FOXO1, FOXO3, GYS1, 
IGF1R, IRS2, PIK3CD, PFKL 
Porphyrin and chlorophyll metabolism 1.50E-02 6 ALAS2, ALAD, BLVRB, EPRS, HMBS, UROD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 76
Figure 2.1 Heme Biosynthetic Gene Expression Levels from Time of Initial Vaccination to 48 Days Post-Vaccination 
 
A) Genes with FPKM > 500 at d0. 
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  X-axis represents days of sample collection 
  Y-axis represents average of reads in Fragments Per Kilobase Million 
  SLC25A39     Solute carrier family 25 member 39 
  ATPIF1          ATPase inhibitory factor 1  
  ALAS2           5'-Aminolevulinate Synthase 2 
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B) Genes with FPKM < 500 at d0 
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     X-axis represents days of sample collection 
     Y-axis represents average of reads in Fragments Per Kilobase Million` 
     HMBS      Hydroxymethylbilane Synthase 
     ALAD      Delta-aminolevulinic acid dehydratase   
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Figure 2.2 FOXO Signaling Pathway for Decreased in Abundance Genes at Day 21 Post-Vaccination 
  
 
   Red stars represent significant differential gene expression in our study.  
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Appendix A: PAXgene Blood RNA kit Extraction Protocol 
 Blood samples were thawed at room temperature for at least two hours before 
starting the extraction and centrifuged for 10 minutes at 4000xg.  After removing the 
supernatant, 6 mL of RBC lysis buffer was added to each sample and vortexed until pellet 
was dissolved for approximately 5 minutes. Tubes were centrifuged for 10 minutes at 
3000xg and the supernatant was discarded. Each tube was loaded with 4 mL of RNase 
free water. The tubes were vortexed until pellet was dissolved and centrifuged again for 
10 minutes at 3000xg. After discarding all of the supernatant, 350 µl of BR1 buffer was 
added to each tube and vortexed until pellet was dissolved. Samples were transferred into 
a 1.5 mL microcentrifuge tube. BR2 buffer (300 µl) and 40 µl of proteinase K were 
added to each sample, samples were vortexed for 5 seconds, and then incubated for 10 
minutes at 55°C in a shaker-incubator (~140 rpm on the settings). Approximately 700 µl 
of lysate was pipetted into a LILAC spin column and spun for 3 minutes at 14,000xg. 
Without bumping pellet, flow-through was transferred into a fresh 1.5 mL 
microcentrifuge tube. 100% ethanol (350 µl) was added to each tube, vortexed, and 
briefly centrifuged. Sample (700 µl) was pipetted into the RED spin column, and spun for 
1 minute at 14,000xg. The spin column was placed into a new collection tube, and the old 
tube with flow-through was discarded. BR3 (350 µl) buffer was added onto the spin 
column and centrifuged for 1 minute at 14,000xg. The spin column was placed into a new 
collection tube and the old tube with flow-through was discarded a second time. DNase I 
(10 µl) was added to 70 µl of RDD buffer in a new 1.5mL tube and then gently flicked to 
mix. DNase I and RDD buffer mixture (80 µl) was added onto the spin column and 
incubated at room temperature for 15 minutes. BR3 buffer (350 µl) was added onto the 
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spin column and spun for 1 minute at 14,000xg. The spin column was placed into a new 
collection tube and the old tube and flow-through was discarded. BR4 buffer (500 µl) 
was added onto the spin column and spun for 1 minute at 14,000xg. The spin column was 
placed into a new collection tube and the old tube with flow-through was discarded again. 
Another 500 µl of BR4 buffer was added onto the spin column and spun for 3 minutes at 
14,000xg. Again, the spin column placed into new collection tube and the old tube with 
flow-through was discarded. To remove the remaining buffer, the spin column was spun 
again for 1 minute at 14,000xg and flow-through tube was discarded. Finally, the spin 
column was placed into a new 1.5 mL microcentrifuge tube. BR5 buffer (40 µl) was 
directly pipetted onto the spin column membrane and spun for 1 minute at 14,000xg. The 
previous step was repeated with the addition of 40 µl of BR5 buffer using the same 
collection tube. After the spin column was discarded, the 1.5 mL tube was then incubated 
for exactly 5 minutes at 65°C using a hot-plate (no-shaking), and immediately was 
moved to ice. The RNA samples were quantified with a Nanodrop ND-1000 
spectrophotometer and stored in -80°C freezer. 
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Appendix B: SYBR Green One-Step Kit Reaction Mix Preparation Protocol 
 
        Frozen iTaq Universal SYBR Green reaction mix (2x) and iScript reverse 
transcriptase were thawed to 4°C or room temperature and then mixed thoroughly and 
centrifuged briefly for 3 to 4 seconds. First, the reaction setup was prepared for all PCR 
reactions by adding each required component except RNA including 5 µl of iTaq 
Universal SYBR Green, 0.125 µl of iScript reverse transcriptase and 0.3 µl of each 
forward and reverse primer. The reaction setup was spun briefly to ensure homogeneity 
and then 5.725 µl of reaction setup was pipetted into each reaction well of a PCR plate. 
Finally, 4 µl of RNA samples (40 ng) were added to the wells and 0.275 µl of nuclease-
free water was added to each well for a total volume of 10 µl. The PCR reaction for each 
RNA sample was performed in duplicate. Also, one well of the PCR plate was a negative 
control with no template and another well had no reverse transcriptase (no RT enzyme). 
  
  
